Less Ads, More Data, More Tools Register for FREE

Texas Instrument's Agreement

18 Mar 2008 09:31

Immediate Release: Tuesday 18 March 2008

Nanoscience Inc. ('Nanoscience' or the `Group') Strategic Licensing and Distribution Agreement

Nanoscience Inc. is pleased to announce that its wholly-owned subsidiary Toumaz Technology ('Toumaz') has signed a strategic licensing and distribution agreement with Texas Instruments Inc ('TI').

Under the terms of this strategic relationship, Toumaz will have access to TI's design, process, and manufacturing capabilities as well as an opportunity to use TI's sales channel and have access to its established customer base.

Further details of the arrangements will be made available in due course.

Guy Spelman, CEO, commented:

'This is an important relationship for Toumaz and reflects the continued progress the business is making and we look forward to working with such a quality business in the future.'

-Ends-

Further information:

Guy Spelman Nanoscience Inc. 07767 338 967

Tim Goodman Ambrian Partners 020 7634 4705

Andrew Tan Hansard Group 020 7245 1100

www.hansardgroup.co.uk

About Nanoscience Inc.:

Nanoscience is a specialist niche investor in emerging technologies with a strong commercial proposition from within the medical technology and semiconductor sectors.

About Toumaz (www.toumaz.com):

Toumaz, winner of the first prize at the fifth Oracle Partner Network (OPN) Innovation Awards for Europe, the Middle East and Africa and the IET Innovation Award for Electronics 2007 is a developer of advanced RF, analogue and mixed signal semiconductors. The focus of the business is low power devices based on the company's proprietary AMx¢â€ž¢ (Advanced Mixed Signal) technology which addresses the needs of lower power consumption for mobile and wirelessly connected systems.

NANOSCIENCE INC

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS